Other competitors in the healthcare sector include: Baxter International (BAX), Viropharma (VPHM), and Abbott Laboratories (ABT).
Below is a three month price history chart comparing the stock performance of MMM, versus MDT and BAX.
High Sheriff Michael Bax, who lives at the farm, unveiled a memorial plaque.
Baxter International (BAX) reports its third quarter earnings on Thursday, October 18, 2012.
Baxter International (BAX) reports its fourth quarter earnings on Thursday, January 24, 2013.
Mark Oliver, 30, Malcolm Bax, 31, Andrew Robinson, 46, and Michael Hopkins, 51, were found guilty of knowingly importing the drugs.
BBC: Men jailed for Heathrow Airport cocaine smuggle attempt
Then, at college, he sold his recordings of Arnold Bax's symphonies to buy Pere Ubu and Sonic Youth, and hung out at punk clubs in Berkeley.
According to the ETF Finder at ETF Channel, BAX makes up 2.57% of the Dynamic Pharmaceuticals Portfolio ETF ( AMEX: PJP )which is trading up by about 0.9% on the day Thursday.
FORBES: BAX Makes Bullish Cross Above Critical Moving Average
Among the largest underlying components of IYH, in trading today Bristol-Myers Squibb Co. ( NYSE: BMY) is up about 0.4%, Medtronic, Inc. ( NYSE: MDT) is up about 1.5%, and Baxter International Inc. ( NYSE: BAX) is higher by about 0.1%.
Among the largest underlying components of XLV, in trading today UnitedHealth Group Inc. ( NYSE: UNH) is down about 0.5%, Medtronic Incorporated ( NYSE: MDT) is off about 0.5%, and Baxter International Incorporated ( NYSE: BAX) is lower by about 0.6%.
Among the largest underlying components of IXJ, in trading today Gilead Sciences Incorporated ( NASD: GILD) is down about 1.6%, Baxter International Incorporated ( NYSE: BAX) is off about 2.4%, and Biogen Idec Incorporated ( NASD: BIIB) is lower by about 1.6%.
Among the largest underlying components of XLV, in trading today Express Scripts Holdings Co ( NASD: ESRX) is up about 0.3%, Medtronic, Inc. ( NYSE: MDT) is down about 0.4%, and Baxter International Inc. ( NYSE: BAX) is lower by about 0.8%.
Jay Mayesh, a product liability defense lawyer at Kaye Scholer who represented Pfizer and Baxter International (nyse: BAX - news - people ) in drug and device litigation, at first said that it was difficult to say how bad the case would be for Merck.
应用推荐